Cel Sci Corporation
Biotechnology, 8229 Boone BLVD Ste 802, Vienna, Virginia, 22182, United States, 11-50 Employees
Phone Number: 70********
Who is CEL-SCI CORPORATION
CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. CEL-SC...
Read More
-
Headquarters: 8229 Boone BLVD Ste 802, Vienna, Virginia, 22182, United States
-
Date Founded: 1983
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2259
|
NAICS Code: 32 |
Show More
Does something look wrong? Fix it. | View contact records from CEL-SCI CORPORATION
CEL-SCI Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CEL-SCI Corporation
Answer: CEL-SCI Corporation's headquarters are located at 8229 Boone BLVD Ste 802, Vienna, Virginia, 22182, United States
Answer: CEL-SCI Corporation's phone number is 70********
Answer: CEL-SCI Corporation's official website is https://cel-sci.com
Answer: CEL-SCI Corporation's revenue is $1 Million to $5 Million
Answer: CEL-SCI Corporation's SIC: 2259
Answer: CEL-SCI Corporation's NAICS: 32
Answer: CEL-SCI Corporation has 11-50 employees
Answer: CEL-SCI Corporation is in Biotechnology
Answer: CEL-SCI Corporation contact info: Phone number: 70******** Website: https://cel-sci.com
Answer: CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. CEL-SCI's lead investigational therapy, Multikine* (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent aimed at harnessing the patient's own immune system to produce an anti-tumor response. Data from Phase I and Phase II clinical trials suggest that Multikine simulates the activities of a healthy person's immune system, enabling it to use the body's own anti-tumor immune response. Multikine is the trademark we have registered for this investigational therapy, and this proprietary name is subject to review by the U.S. Food and Drug Administration, or FDA, in connection with our future anticipated regulatory submission for approval.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month